Skip to content

Enovis ENOV Reconstructive — Adjusted EBITDA (non-GAAP)

Similar metrics at other companies

Select Medical Holdings logo
SEMRehabilitation Hospital — Adjusted EBITDA
$81.08M+15.1%
Adient logo
ADNTAdjusted EBITDA
$246M-3.1%
Select Medical Holdings logo
SEMOutpatient Rehabilitation — Adjusted EBITDA
$21.98M-9.4%
Playtika Holding Corp. logo
PLTKAdjusted EBITDA
$188.3M-0.6%
Worthington Enterprises logo
WORConsumer Products — Adjusted EBITDA
$35.45M+23.8%
Lamar Advertising logo
LAMRReportable Segment — Adjusted EBITDA
$226.45M+7.7%

Other financials

Income statement

See full
Revenue$589.2M+5.4%
Gross profit$365.5M+10.0%
Operating income$6.5M+114%
Net income-$8.8M+84.3%
EPS (diluted)-$0.15+84.7%

Balance sheet

See full
Cash & equivalents$33.1M-13.9%
Total debt$1.4B-3.1%
Total equity$1.5B-43.6%
Total assets$3.8B-21.4%

Cash flow

See full
Operating cash flow$24.0M+1,601%
CapEx$52.8M+22.1%
Free cash flow-$28.9M+35.7%

Valuation

See full
Market cap$1.23B-40.2%
Enterprise value$2.55B-25.8%
P/S0.5×-0.4×

Profitability

See full
Gross margin60.5%+4.0pp
Operating margin-47%+18.6pp
Net margin-49.9%+24.1pp
FCF margin-3.1%-1.1pp

Returns & leverage

See full
Return on equity-55.5%-1,722pp
Debt / equity0.9×+0.4×
Current ratio-0.5×

Where this comes from

Reported directly by Enovis in its filing.

Tagged under the XBRL concept cfx:SegmentOperatingIncome.

The official record: Enovis’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Enovis's reconstructive — adjusted ebitda (non-gaap).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Enovis's reconstructive — adjusted EBITDA (non-gaap)?
Enovis (ENOV) reported reconstructive — adjusted EBITDA (non-gaap) of $72.46M in Q1 2026.
How has Enovis's reconstructive — adjusted EBITDA (non-gaap) changed year-over-year?
Enovis's reconstructive — adjusted EBITDA (non-gaap) increased by 6.1% year-over-year, from $68.3M to $72.46M.
What is the long-term trend for Enovis's reconstructive — adjusted EBITDA (non-gaap)?
Over 4 years (2021 to 2025), Enovis's reconstructive — adjusted EBITDA (non-gaap) has grown at a 34.9% compound annual growth rate (CAGR), from $72.5M to $239.93M.
What does reconstructive — adjusted EBITDA (non-gaap) mean?
This non-GAAP measure represents the operating profitability of the Reconstructive segment before interest, taxes, depreciation, and amortization, adjusted for non-recurring items. It provides a clearer view of the segment's core operational cash-generating ability by excluding non-cash expenses and one-time charges. This is a key indicator of the segment's underlying performance and scalability.